Home / HEADLINES / INDIA / COVAXIN clinical trials cross 13,000 subjects, half way mark and forges ahead, India’s largest Phase III trials
COVAXIN clinical trials cross 13,000 subjects, half way mark and forges ahead, India’s largest Phase III trials
2020-12-22